安邦制药 (874011.oc)

+ 收藏

资产负债表(安邦制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表
流动资产:
 货币资金(元) 119,865,927.20118,877,062.20191,483,579.2294,949,364.00
 应收票据及应收账款(元) 32,678,296.8417,903,232.4224,665,188.4120,225,227.51
  其中:应收票据(元) 5,299,896.563,714,480.186,707,292.423,183,903.48
  其中:应收账款(元) 27,378,400.2814,188,752.2417,957,895.9917,041,324.03
 预付款项(元) 5,847,648.6713,532,075.8013,780,296.833,061,079.93
 其他应收款(元) 1,298,575.171,955,471.851,237,494.371,754,283.40
 存货(元) 63,792,422.6865,153,890.0850,911,835.7647,886,718.88
 其他流动资产(元) 2,018,418.632,823,037.531,013,514.23582,336.20
 流动资产合计(元) 225,776,289.19220,825,169.88286,258,723.42172,183,942.45
非流动资产:
 固定资产(元) 53,038,090.4255,767,197.8158,108,287.0858,110,230.48
 在建工程(元) 85,999.70-381,000.001,603,174.45
 使用权资产(元) 557,161.792,202,889.172,803,677.153,404,465.13
 无形资产(元) 14,366,513.4816,273,531.7712,263,699.9510,138,025.70
 开发支出(元) --5,949,056.585,900,000.00
 长期待摊费用(元) 188,458.12245,337.72327,115.14421,341.50
 递延所得税资产(元) 8,804,525.088,816,512.989,924,179.6610,333,773.28
 其他非流动资产(元) 737,700.00573,000.00633,142.003,576,324.70
 非流动资产合计(元) 77,778,448.5983,878,469.4590,390,157.5693,487,335.24
资产总计(元) 303,554,737.78304,703,639.33376,648,880.98265,671,277.69
流动负债:
 短期借款(元) -4,116,526.62-227,000.00
 应付票据及应付账款(元) 33,985,662.3134,106,330.5729,111,450.1223,145,126.73
  其中:应付票据(元) 7,523,900.264,685,878.008,433,250.00-
  其中:应付账款(元) 26,461,762.0529,420,452.5720,678,200.1223,145,126.73
 合同负债(元) 5,550,590.1310,067,485.7368,921,010.9314,472,380.22
 应付职工薪酬(元) 7,690,533.467,033,375.7214,933,659.074,577,494.79
 应交税费(元) 2,563,053.801,238,903.116,168,508.221,307,553.04
 其他应付款(元) 14,571,640.6616,402,057.6216,406,295.2313,626,191.56
 一年内到期的非流动负债(元) 197,626.161,301,107.381,276,761.831,252,871.82
 其他流动负债(元) 5,753,857.424,873,253.3214,140,562.053,917,031.90
 流动负债合计(元) 70,312,963.9479,139,040.07150,958,247.4562,525,650.06
非流动负债:
 租赁负债(元) 207,013.39669,219.601,325,917.161,970,326.98
 递延收益(元) 3,822,457.233,295,260.073,691,139.834,087,019.59
 递延所得税负债(元) 715,490.32668,288.49682,158.921,163,546.49
 非流动负债合计(元) 4,744,960.944,632,768.165,699,215.917,220,893.06
负债合计(元) 75,057,924.8883,771,808.23156,657,463.3669,746,543.12
所有者权益(或股东权益):
 实收资本或股本(元) 60,706,000.0060,706,000.0060,000,000.0060,000,000.00
 资本公积(元) 75,822,105.7075,822,105.7066,837,293.2566,837,293.25
 盈余公积(元) 11,764,857.078,097,356.438,097,356.435,106,470.64
 未分配利润(元) 70,427,459.3766,119,569.2675,707,072.7955,716,031.17
 归属于母公司股东权益合计(元) 218,720,422.14210,745,031.39210,641,722.47187,659,795.06
 少数股东权益(元) 9,776,390.7610,186,799.719,349,695.158,264,939.51
 股东权益合计(元) 228,496,812.90220,931,831.10219,991,417.62195,924,734.57
负债和股东权益合计(元) 303,554,737.78304,703,639.33376,648,880.98265,671,277.69
公告日期 2024-04-262023-08-282023-03-242022-12-01
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院